Psychosis Clinical Trials in New Haven, Connecticut
2 recruitingNew Haven, Connecticut
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis
Clinical High Risk for Psychosis (CHR)
Monument Therapeutics Limited150 enrolled15 locationsNCT07226895
Recruiting
Early Phase 1
Toward a Computationally-Informed, Personalized Treatment for Hallucinations
PsychosisHallucinations, Auditory
Yale University35 enrolled1 locationNCT04366518